aDivision of HIV, Infectious Disease, & Global Medicine, University of California, San Francisco, CA
bKenya Medical Research Institute, Nairobi, Kenya;
cUniversity of Massachusetts Amherst, Amherst, MA
dSchool of Public Health, University of California, Berkeley, CA
Correspondence to: Matthew D. Hickey, Division of HIV, Infectious Disease & Global Medicine, Department of Medicine, San Francisco General Hospital, University of California, 995 Potrero Avenue, Ward 84, San Francisco, CA 94110 (e-mail: [email protected]).
This research was supported by grants from the National Institutes of Health: UCSF-Gladstone Center for AIDS Research (P30 AI027763), T32 AI060530, U01 AI1505010, and K23HL162578.
The authors have no funding or conflicts of interest to disclose.
Results from this study were previously presented at the Conference on Retroviruses and Opportunistic Infections, Denver CO, United States, in February 2022
L.B.B. and J.A. contributed equally to this work.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jaids.com).
